A number of different mechanisms, including the upregulation of other angiogenic pathways such as the Notch pathway, have been described to play a role in the development of tumor vessels that are insensitive to anti-VEGF therapy [4,14,15,34]. The gene discussed is VEGFA; the disease is neoplasm.